Deldacan, Jana Mae A.
HRN: 29-02-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/02/2026
06/08/2026
IV
9gm
Q6
CAP MR Acinetobacter
Checking Initial Appropriateness
Indication: Culture-directed Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines